Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Status:
Recruiting
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of
gastric cancer in the early gastric cancer patients with negative H. pylori status who
underwent endoscopic submucosal dissection.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Center, Korea
Collaborators:
Asan Medical Center Chilgok Kyungpook National University Chonnam National University Hospital Chung-Ang University Hosptial, Chung-Ang University College of Medicine Hallym University Medical Center Incheon St.Mary's Hospital/The Catholic University Kosin University Gospel Hospital Pusan National University Hospital Seoul National University Hospital SMG-SNU Boramae Medical Center